Clinical Trials
3 trialsNCT07619898 2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2 Not yet recruiting
NCT06646016 2025-12-26
EPIC
Therakos LLC
Phase 2 Withdrawn
NCT02723006 2024-03-05
Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma
Takeda
Phase 1 Terminated